Alicia M Hanson1, K L Iresha Sampathi Perera2, Jaekyoon Kim3, Rajesh K Pandey2, Noreena Sweeney1, Xingyun Lu1, Andrea Imhoff1, Alexander Craig Mackinnon4, Adam J Wargolet5, Rochelle M Van Hart5, Karyn M Frick3, William A Donaldson2, Daniel S Sem1. 1. Department of Pharmaceutical Sciences, Center for Structure-Based Drug Design and Development , Concordia University Wisconsin , Mequon , Wisconsin 53097 , United States. 2. Department of Chemistry , Marquette University , P.O. Box 1881, Milwaukee , Wisconsin 53201-1881 , United States. 3. Department of Psychology , University of Wisconsin-Milwaukee , 2441 East Hartford Avenue , Milwaukee , Wisconsin 53211 , United States. 4. Department of Pathology , Medical College of Wisconsin , 9200 West Wisconsin Avenue , Milwaukee , Wisconsin 53226 , United States. 5. Department of Natural Science , Concordia University Wisconsin , Mequon , Wisconsin 53097 , United States.
Abstract
Estrogen receptor-beta (ERβ) is a drug target for memory consolidation in postmenopausal women. Herein is reported a series of potent and selective ERβ agonists (SERBAs) with in vivo efficacy that are A-C estrogens, lacking the B and D estrogen rings. The most potent and selective A-C estrogen is selective for activating ER relative to seven other nuclear hormone receptors, with a surprising 750-fold selectivity for the β over α isoform and with EC50s of 20-30 nM in cell-based and direct binding assays. Comparison of potency in different assays suggests that the ER isoform selectivity is related to the compound's ability to drive the productive conformational change needed to activate transcription. The compound also shows in vivo efficacy after microinfusion into the dorsal hippocampus and after intraperitoneal injection (0.5 mg/kg) or oral gavage (0.5 mg/kg). This simple yet novel A-C estrogen is selective, brain penetrant, and facilitates memory consolidation.
Estrogen receptor-beta (ERβ) is a drug tn class="Gene">arget for memory consolidation in postmenopausal women. Herein is reported a series of potent and selective ERβ agonists (SERBAs) with in vivo efficacy that are A-C estrogens, lacking the B and D estrogen rings. The most potent and selective A-C estrogen is selective for activating ER relative to seven other nuclear hormone receptors, with a surprising 750-fold selectivity for the β over α isoform and with EC50s of 20-30 nM in cell-based and direct binding assays. Comparison of potency in different assays suggests that the ER isoform selectivity is related to the compound's ability to drive the productive conformational change needed to activate transcription. The compound also shows in vivo efficacy after microinfusion into the dorsal hippocampus and after intraperitoneal injection (0.5 mg/kg) or oral gavage (0.5 mg/kg). This simple yet novel A-C estrogen is selective, brain penetrant, and facilitates memory consolidation.
Authors: Sophie E Holmes; Irina Esterlis; Carolyn M Mazure; Yen Ying Lim; David Ames; Stephanie Rainey-Smith; Ralph N Martins; Olivier Salvado; Vincent Dore; Victor L Villemagne; Christopher C Rowe; Simon M Laws; Colin L Masters; Paul Maruff; Robert H Pietrzak Journal: Am J Geriatr Psychiatry Date: 2016-08-17 Impact factor: 4.105
Authors: Muhammad Asim; Daria Klonowska; Christine Choueiri; Ilia Korobkov; Kathryn E Carlson; John A Katzenellenbogen; Tony Durst Journal: Bioorg Med Chem Lett Date: 2012-04-11 Impact factor: 2.823
Authors: M J Meyers; J Sun; K E Carlson; G A Marriner; B S Katzenellenbogen; J A Katzenellenbogen Journal: J Med Chem Date: 2001-11-22 Impact factor: 7.446
Authors: Michael S Malamas; Eric S Manas; Robert E McDevitt; Iwan Gunawan; Zhang B Xu; Michael D Collini; Chris P Miller; Tam Dinh; Ruth A Henderson; James C Keith; Heather A Harris Journal: J Med Chem Date: 2004-10-07 Impact factor: 7.446
Authors: Luis F Jacome; Claris Gautreaux; Tomoko Inagaki; Govini Mohan; Stephen Alves; Laura S Lubbers; Victoria Luine Journal: Neurobiol Learn Mem Date: 2010-09-07 Impact factor: 2.877
Authors: L A Farrer; L A Cupples; J L Haines; B Hyman; W A Kukull; R Mayeux; R H Myers; M A Pericak-Vance; N Risch; C M van Duijn Journal: JAMA Date: 1997 Oct 22-29 Impact factor: 56.272
Authors: Miriam Pillerová; Veronika Borbélyová; Michal Pastorek; Vladimír Riljak; Július Hodosy; Karyn M Frick; L'ubomíra Tóthová Journal: Front Psychiatry Date: 2022-09-08 Impact factor: 5.435
Authors: Aaron W Fleischer; Jayson C Schalk; Edward A Wetzel; Alicia M Hanson; Daniel S Sem; William A Donaldson; Karyn M Frick Journal: Horm Behav Date: 2021-03-08 Impact factor: 3.587